Document Detail

Rivaroxaban, a direct inhibitor of the coagulation factor Xa interferes with hormonal- induced physiological modulations in human female osteoblastic cell line SaSO(2).
MedLine Citation:
PMID:  23333933     Owner:  NLM     Status:  Publisher    
The use of anticoagulants has been associated with systemic osteoporosis and increased risk for poor fracture healing but is inevitable following major orthopedic surgery of lower limbs. Rivaroxaban A (R) is an anticoagulant recently introduced in the clinical setting, which is a specific factor Xa inhibitor. We reported previously that R significantly inhibited cell growth, energy metabolism and alkaline phosphatase activity in human osteoblastic cell line SaOS(2), with no effect on mineralization, indicating transient inhibition of bone formation. We now investigated the effects of R on SaOS(2) response to osteoblast-modulating hormones. At sub-confluence cells were treated with: estradiol-17β (E(2)), the phytoestrogens daidzein (D) and biochainin A (BA), the carboxy- pytoestrogenic derivative carboxy-D (cD), the estrogen receptor α (ERα) agonist PPT, the estrogen receptor β (ERβ) agonist DPN, parathyroid hormone (PTH) and several vitamin D metabolites and analogs with/without R for 24h. All hormones tested stimulated significantly DNA synthesis (DNA), creatine kinase (CK) and alkaline phosphatase (ALP) specific activities, but all these stimulations were totally inhibited when given together with R. R had no effect on mRNA expression of ERα, ERβ and 25 Hydroxy- vitamin D(3)- 1α hydroxylase (1OHase), but inhibited hormonal modulations of mRNA expressions. In conclusion R inhibited significantly hormonal stimulation of different parameters indicating inhibition of not only the early stages of bone formation, but also the stimulatory effects of bone modulating hormones with a yet unclear mechanism. The relevance of these findings to human bone physiology is yet to be investigated.
Dalia Somjen; Sara Katzburg; Roi Gigi; Oleg Dolkart; Orli Sharon; Moshe Salai; Naftali Stern
Related Documents :
18406193 - Ve-cadherin and ace: markers for sepsis in post mortem examination?
25040843 - Functional analysis of fractalkine gene promoter in human aortic smooth muscle cells ex...
12706083 - Characterization of the immediate-early 2 protein of human herpesvirus 6, a promiscuous...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-17
Journal Detail:
Title:  The Journal of steroid biochemistry and molecular biology     Volume:  -     ISSN:  1879-1220     ISO Abbreviation:  J. Steroid Biochem. Mol. Biol.     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-21     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9015483     Medline TA:  J Steroid Biochem Mol Biol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2013. Published by Elsevier Ltd.
Institute of Endocrinology, Metabolism and Hypertension and *Division of Orthopedic Surgery, Tel- Aviv Sourasky Medical Center and the Sackler Faculty of Medicine, Tel- Aviv University, Tel- Aviv 64239, Israel. Electronic address:
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  1,25(OH)2 vitamin D suppresses macrophage migration and reverses atherogenic cholesterol metabolism ...
Next Document:  Fetal origin of endocrine dysfunction in the adult: the phthalate model.